Nano Letters
Biohybrid Fused-Cell Carrier for Programmable Therapeutic Modulation of Atherosclerosis
Experiments in animalsInterventions
The paper
Beijing Institute of Technology
Nano Letters, 2 Sep 2026
Beijing Institute of Technology
Nano Letters, 2 Sep 2026
Advanced Materials9 Oct 2026

Advanced Materials2 Oct 2026

International Immunopharmacology3 Oct 2026

Biomaterials Advances2 Oct 2026